Filing Details
- Accession Number:
- 0001291656-15-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-16 11:26:15
- Reporting Period:
- 2015-03-12
- Filing Date:
- 2015-03-16
- Accepted Time:
- 2015-03-16 11:26:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
880771 | Sciclone Pharmaceuticals Inc | SCLN | Pharmaceutical Preparations (2834) | 943116852 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1291656 | Wai-Shun Wilson Cheung | 950 Tower Lane, Suite 900 Foster City CA 94404 | Cfo & Senior Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-03-12 | 7,803 | $9.07 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2014.